Quick Guide to Oncology & Hematology

Caidya partners with biopharma innovators to bring clarity and confidence to oncology and hematology drug development. With flexible trial design and agile execution, we accelerate timelines while maintaining precision and quality. Our scalable approach and strong global footprint allow us to seamlessly navigate the evolving landscape of oncology and hematology research—supporting both regional and global needs with the speed and adaptability today’s trials demand.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

11/20/2025

Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI-Powered Experiences

New Experiences solutions, including Medidata CTMS and Medidata Clinical Data...

09/19/2025

Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board

RALEIGH, N.C.; September 19, 2025 – Caidya, a leading global...

07/21/2025

Caidya’s John Wang Named Chair of China CDISC Coordinating Committee; Medidata Accreditation Underscores Data Management Excellence

RALEIGH, N.C.; July 22, 2025 – Caidya a global, technology-enabled clinical...
Skip to toolbar